M Francisca Portilha-Cunha

Mrs. M Francisca Portilha-Cunha

Faculty of Engineering, University of Porto
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Foods
Verified
Journal Article
Open access
PDF file
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
Angela C. MacedoAngela C. Macedo
Angela C. Macedo
FMFrancisco Malcata
Francisco Malcata
Spontaneous fermentation constitutes the basis of the chief natural method of processing of table olives, where autochthonous strains of lactic acid bacteria (LAB) play a dominant role. A thorough literature search has unfolded 197 reports worldwide, published in the last two decades, that indicate an increasing interest in table olive-borne LAB, especially in Mediterranean countries. This review attempted to extract extra information from such a large body of work, namely, in terms of correlations between LAB strains isolated, manufacture processes, olive types, and geographical regions. Spain produces mostly green olives by Spanish-style treatment, whereas Italy and Greece produce mainly green and black olives, respectively, by both natural and Spanish-style. More than 40 species belonging to nine genera of LAB have been described; the genus most often cited is Lactobacillus, with L. plantarum and L. pentosus as most frequent species—irrespective of country, processing method, or olive type. Certain LAB species are typically associated with cultivar, e.g., Lactobacillus parafarraginis with Spanish Manzanilla, or L. paraplantarum with Greek Kalamata and Conservolea, Portuguese Galega, and Italian Tonda di Cagliari. Despite the potential of native LAB to serve as starter cultures, extensive research and development efforts are still needed before this becomes a commercial reality in table olive fermentation.

31 July 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
SRSara Ramos
Sara Ramos
Adriano dos Santos SilvaAdriano dos Santos Silva
Adriano dos Santos Silva
PNPedro Norton
Pedro Norton
AAA. Alves
A. Alves
Mónica SantosMónica Santos
Mónica Santos
Cytostatics are drugs used in cancer treatment, which pose serious risks to healthcare workers. Dermal absorption via surface contamination is the key exposure route; thus, rapid, reliable, and validated analytical methods for multicomponent detection are crucial to identify the exposure risk. A surface-wipe-sampling technique compatible with hospitals’ safety requirements (gauze, 1 mL isopropanol) and a fast and simple extraction method (1 mL acetonitrile, 20 min ultrasonic bath, evaporation, reconstitution in 200 µL acetonitrile), coupled with liquid chromatography–tandem mass spectrometry analysis, were developed. It allowed identification and quantification of 13 cytostatics on surfaces: cyclophosphamide, doxorubicin, etoposide, ifosfamide, paclitaxel, bicalutamide, capecitabine, cyproterone, flutamide, imatinib, megestrol, mycophenolate mofetil, prednisone. Good linearity, sensitivity, and precision were achieved (R2 > 0.997, IDLs < 4.0 pg/cm2, average CV 16%, respectively). Accuracy for four model surfaces (melamine-coated wood, phenolic compact, steel 304, steel 316) was acceptable (80 ± 12%), except for capecitabine and doxorubicin. Global uncertainty is below 35% for concentrations above 100 pg/cm2 (except for capecitabine and doxorubicin)—a guidance value for relevant contamination. Method application in a Portuguese university hospital (28 samples) identified the presence of seven cytostatics, at concentrations below 100 pg/cm2, except for three samples. The widespread presence of cyclophosphamide evinces the necessity to review implemented procedures.

15 June 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
AAA. Alves
A. Alves
Mónica SantosMónica Santos
Mónica Santos
Periodic and adequate environmental monitoring programs are crucial to assess and reduce the occupational exposure of healthcare workers to cytostatics. The analytical methods employed should be rapid, reliable, sensitive, standardized, and include multiple compounds. A critical overview of recent overall procedures for surface and air contamination with cytostatics in workplace settings is presented, with a focus on sampling, sample preparation, and instrumental considerations. Limitations are also addressed and some recommendations and advice are provided. Since dermal absorption is the main exposure route, surface contamination is the preferred indicator of biological uptake and its methods have significantly improved. In contrast, cytostatics’ inhalation is rare; thus, air contamination has been poorly studied, with little improvement. Still, some elements of the analytical methods have not been extensively explored, namely: the amount of wetting solution, the extraction procedure, surface chemistry and roughness, recovery studies from specific surfaces, and cytostatics stability (in surfaces and during shipping and storage). Furthermore, complete validation data (including precision, accuracy, and instrumental and method detection limits) and estimation of global uncertainty are still lacking in most studies, thus preventing method comparison and proposal of standardized procedures.

21 January 2025 in Journal of Occupational and Environmental Hygiene
Verified
Journal Article
Closed access
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
PNPedro Norton
Pedro Norton
AAA. Alves
A. Alves
Ana RibeiroAna Ribeiro
Ana Ribeiro
Adriano dos Santos SilvaAdriano dos Santos Silva
Adriano dos Santos Silva
Mónica SantosMónica Santos
Mónica Santos
Effective decontamination of hospital surfaces is crucial to protect workers from antineoplastic drugs (ADs) since dermal absorption is the main exposure route to these hazardous medicinal products. Sampling after daily cleaning in oncologic settings from a tertiary hospital was initially performed and exhibited low contamination levels; however, cyclophosphamide was still found (up to 957 pg/cm2) above the guidance value (100 pg/cm2) in four locations, evidencing the need to properly assess and update the cleaning protocols. Then, cleaning efficiencies of six solutions and different protocols were evaluated (including, for the first time, four commercial cleaning solutions/disinfectants not designed specifically for AD removal) after deliberate contamination of three model surfaces with 13 pharmaceuticals: bicalutamide, capecitabine, cyclophosphamide, cyproterone, doxorubicin, etoposide, flutamide, ifosfamide, imatinib, megestrol, mycophenolate mofetil, paclitaxel, and prednisone. Wipe sampling and liquid chromatography-tandem mass spectrometry were employed to determine surface contamination after cleaning. Results revealed that: (i) none of the solutions or procedures totally removed all target pharmaceuticals from surfaces; (ii) the removal efficiency increased with cleaning steps (average removals above 90% were attained for Vyclean and Clinell Universal Spray using two cleaning steps); and (iii) the cleaning efficiency was likely favored by the application of the solution/disinfectant directly on the surfaces. Therefore, considering the dissimilar chemical structures and properties of the numerous ADs in use, the cleaning agent and protocol should be adjusted to the reality of each healthcare unit. Still, the scientific community is encouraged to develop a cleaning solution/protocol to simultaneously eliminate/remove as many ADs as possible.

13 September 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
TGTeresa Gouveia
Teresa Gouveia
Alicia Loreto García CostaAlicia Loreto García Costa
Alicia Loreto García Costa
AAA. Alves
A. Alves
Mónica SantosMónica Santos
Mónica Santos
Cytostatics are toxic pharmaceuticals, whose presence in surfaces puts healthcare workers at risk. These drugs might also end up in hospital effluents (HWW), potentially damaging aquatic ecosystems. Bicalutamide is a cytostatic extensively consumed worldwide, but few analytical methods exist for its quantification and most of them require advanced techniques, such as liquid chromatography mass spectrometry (LC-MS), which are very complex and expensive for large monitoring studies. Therefore, a simple but reliable multi-matrix high performance liquid chromatographic method, with fluorescence detection, was developed and validated to rapidly screen abnormal concentrations of bicalutamide in HWW and relevant contamination levels of bicalutamide in indoor surfaces (>100 pg/cm2), prior to confirmation by LC-MS. The method presents good linearity and relatively low method detection limits (HWW: 0.14 ng/mL; surfaces: 0.28 pg/cm2). Global uncertainty was below 20% for concentrations higher than 25 ng/mL (HWW) and 50 pg/cm2 (surfaces); global uncertainty was little affected by the matrix. Therefore, a multi-matrix assessment could be achieved with this method, thus contributing to a holistic quantification of bicalutamide along the cytostatic circuit. Bicalutamide was not detected in any of the grab samples from a Portuguese hospital, but an enlarged sampling is required to conclude about its occurrence and exposure risks.

5 May 2025 in Drug Testing and Analysis
Verified
Journal Article
Open access
RBRoland B. van Den Berg
Roland B. van Den Berg
EKEwelina Korczowska
Ewelina Korczowska
Mónica SantosMónica Santos
Mónica Santos
MPM Francisca Portilha-Cunha
M Francisca Portilha-Cunha
Ana RibeiroAna Ribeiro
Ana Ribeiro
MCMirjam Crul
Mirjam Crul
Workplace monitoring of hazardous medicinal products (HMPs) using surface wipe sampling is becoming common practice in many European hospitals and pharmacies. However, no independent quality control is available to validate wiping procedures and analytical methods. This study aimed to conduct a Europe‐wide interlaboratory comparison (ILC) program to independently and blindly assess laboratory performance and variability in HMP detection. Four European laboratories participated in the study. Six HMPs—cyclophosphamide, etoposide, gemcitabine, ifosfamide, methotrexate, and paclitaxel—were prepared at four concentrations (5000, 2000, 200, and 20 ng/mL) and applied to a 400‐cm 2 stainless‐steel surface, then wiped by the coordinating body according to each laboratory's protocol. Wipe samples were distributed to individual laboratories, where blind analyses were conducted. Target criteria for accuracy and recovery were set at 70%–130% and 50%–130%, respectively. Of the 80 samples, 69 (86%) met accuracy targets, and 70 (88%) met recovery targets. Accuracy was often overestimated for the lowest concentrations of cyclophosphamide, etoposide, methotrexate, and paclitaxel by Laboratory A. Laboratory D showed low accuracy for paclitaxel at three lower concentrations. Among the 10 samples that did not meet recovery targets, all were below 50% and involved etoposide and paclitaxel. This ILC program demonstrates a viable method for evaluating laboratory performance in HMP detection, offering an external validation mechanism for surface wipe sampling methods. A future goal is to establish a global ILC program with a designated coordinating body for managing it effectively.